Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function

Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function

<p>Abstract</p> <p>Objective</p> <p>Patients with severe left ventricular (LV) dysfunction have a poor long term survival despite complete surgical revascularization. Recent data suggests that the use of Implantable Cardioverter-Defibrillator (ICD) improves survival in...

Full description

Bibliographic Details
Main Authors:	Pasque Michael K, Moon Marc R, Lawton Jennifer S, Rahgozar Paymon, Voeller Rochus K, Al-Dadah Ashraf S, Damiano Ralph J, Moazami Nader
Format:	Article
Language:	English
Published:	BMC 2007-01-01
Series:	Journal of Cardiothoracic Surgery
Online Access:	http://www.cardiothoracicsurgery.org/content/2/1/6

Similar Items

Double valve replacement in a patient with implantable cardioverter defibrillator with severe left ventricular dysfunction
by: Girish Manjunath, et al.
Published: (2016-01-01)

Implantable Cardioverter Defibrillator
by: Dicky Armen Hanafy
Published: (2013-07-01)

Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction
by: Laura Jimenez-Juan, MD, et al.
Published: (2017-04-01)

Implantable cardioverter defibrillator as a treatment for massive left ventricular fibroma-induced ventricular arrhythmia in a child
by: In Su Choi, et al.
Published: (2021-05-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

The Automatic External Cardioverter-Defibrillator
by: Antoni Martínez-Rubio, et al.
Published: (2004-07-01)

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device
by: Michele Murphy, MD, et al.
Published: (2016-11-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
by: Viktoria K. Lebedeva, et al.
Published: (2019-03-01)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
by: Luis A. Pires
Published: (2007-08-01)

Externalized biventricular implantable cardioverter-defibrillator
by: Sofia Lázaro Mendes, et al.
Published: (2016-04-01)

In response to, ′Magnets and implantable cardioverter defibrillators′
by: Somsri Wiwanitkit, et al.
Published: (2013-01-01)

Remote Monitoring of Implantable Cardioverter Defibrillator
by: Dwight W. Reynolds, et al.
Published: (2006-10-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Implantable cardioverter defibrillators: state of the art
by: Ray JC, et al.
Published: (2015-04-01)

Externalized biventricular implantable cardioverter-defibrillator
by: Sofia Lázaro Mendes, et al.
Published: (2016-04-01)

Implantable cardioverter defibrillator implantation and degree of left ventricular scarring predict survival in patients with severe ischemic cardiomyopathy
by: Marwick Thomas, et al.
Published: (2011-02-01)

Prognostic value of cardiovascular magnetic resonance left ventricular volumetry and geometry in patients receiving an implantable cardioverter defibrillator
by: Camila M. Urzua Fresno, et al.
Published: (2021-06-01)

RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy
by: Keita Tsukahara, et al.
Published: (2021-08-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Undersensing of ventricular fibrillation by a biventricular implantable cardioverter‐defibrillator: What is the cause and the troubleshooting?
by: Kien Vo Le, et al.
Published: (2019-04-01)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
by: Steven H Back, et al.
Published: (2019-01-01)

Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
by: G. Malanchini, et al.
Published: (2021-04-01)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
by: Abdulkadir Uslu, et al.
Published: (2019-03-01)

Successful Treatment of an Infant with Left Ventricular Noncompaction Presenting with Fatal Ventricular Arrhythmia Treated with Cardiac Resynchronization Therapy and an Implantable Cardioverter Defibrillator
by: Masato Kimura, et al.
Published: (2018-01-01)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
by: Rakesh Malhotra, et al.
Published: (2017-11-01)

Non-invasive evaluation of ventricular refractoriness and its dispersion during ventricular fibrillation in patients with implantable cardioverter defibrillator
by: Ljungström Erik, et al.
Published: (2004-06-01)

Primary Prevention of Fatal Ventricular Arrhythmias With Implantable Cardioverter- Defibrillator Therapy – An Analysis of Implications Based on MADIT II Criteria
by: Zia I Carrim, et al.
Published: (2020-12-01)

Combined etiology of anaphylactic cardiogenic shock: Amiodarone, epinephrine, cardioverter defibrillator, left ventricular assist devices and the Kounis syndrome
by: Nicholas G Kounis, et al.
Published: (2015-01-01)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
by: Alwin B. P. Noordman, et al.
Published: (2021-08-01)

Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients
by: You Zhou, et al.
Published: (2019-05-01)

Malignant ventricular arrhythmias in patients with implantable cardioverter-defibrillators: electrical signals which are predictors of recurrence
by: Ailema A. Alemán-Fernández, et al.
Published: (2017-02-01)

Ventricular Tachycardia Precipitated by Short-long-short Sequence in a Patient with Implantable-cardioverter Defibrillator
by: Diego Chemello, MD, et al.
Published: (2012-01-01)

Molecular mechanisms of heart failure progression associated with implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias
by: Yukiomi Tsuji, MD, PhD, et al.
Published: (2014-08-01)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
by: Anne‐Lotte C.J. van derLingen, et al.
Published: (2021-10-01)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
by: Jin-Jun Liang, et al.
Published: (2019-03-01)

The National Survey of Cardiac Pacemakers and Cardioverter Defibrillators
by: Reza Poorbahador, et al.
Published: (2006-04-01)

Implantation of the cardioverter-defibrillator: Cuban Registry (2017)
by: Marleny Cruz Cardentey, et al.
Published: (2018-07-01)

The National Survey of Cardiac Pacemakers and Cardioverter Defibrillators
by: Gholamrerza Shafieian, et al.
Published: (2006-07-01)

Anaesthetic Management of Patients with Implantable Cardioverter Defibrillator
by: Bukhari Altaf, et al.
Published: (2005-01-01)